关注
Udo Bonnet
标题
引用次数
引用次数
年份
Moclobemide: therapeutic use and clinical studies
U Bonnet
CNS drug reviews 9 (1), 97-140, 2003
3202003
How addictive are gabapentin and pregabalin? A systematic review
U Bonnet, N Scherbaum
European neuropsychopharmacology 27 (12), 1185-1215, 2017
2762017
The cannabis withdrawal syndrome: current insights
U Bonnet, UW Preuss
Substance abuse and rehabilitation, 9-37, 2017
2362017
Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study
M Gastpar, U Bonnet, J Böning, K Mann, LG Schmidt, M Soyka, ...
Journal of Clinical Psychopharmacology 22 (6), 592-598, 2002
1612002
Risks associated with the non-medicinal use of cannabis
E Hoch, U Bonnet, R Thomasius, F Ganzer, U Havemann-Reinecke, ...
Deutsches Ärzteblatt International 112 (16), 271, 2015
1432015
Treatment of alcohol withdrawal syndrome with gabapentin
U Bonnet, M Banger, FM Leweke, M Maschke, T Kowalski, M Gastpar
Pharmacopsychiatry 32 (03), 107-109, 1999
1301999
Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial
U Bonnet, M Banger, FM Leweke, M Specka, BW Müller, T Hashemi, ...
Journal of clinical psychopharmacology 23 (5), 514-519, 2003
1212003
Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons
T Leniger, M Wiemann, D Bingmann, G Widman, A Hufnagel, U Bonnet
Epilepsia 43 (5), 469-474, 2002
852002
Long-term ketamine self-injections in major depressive disorder: focus on tolerance in ketamine’s antidepressant response and the development of ketamine addiction
U Bonnet
Journal of Psychoactive Drugs 47 (4), 276-285, 2015
842015
Modulation of voltage‐gated channel currents by harmaline and harmane
F Splettstoesser, U Bonnet, M Wiemann, D Bingmann, D Büsselberg
British Journal of Pharmacology 144 (1), 52-58, 2005
822005
Intracellular pH modulates spontaneous and epileptiform bioelectric activity of hippocampal CA3-neurones
U Bonnet, D Bingmann, M Wiemann
European Neuropsychopharmacology 10 (2), 97-103, 2000
822000
Selective inhibition of the Na+/H+ exchanger type 3 activates CO2/H+-sensitive medullary neurones
M Wiemann, JR Schwark, U Bonnet, HW Jansen, S Grinstein, RE Baker, ...
Pflügers Archiv 438, 255-262, 1999
711999
Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties
U Bonnet
CNS drug reviews 8 (3), 283-308, 2002
672002
An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol
U Bonnet, R Hamzavi-Abedi, M Specka, J Wiltfang, B Lieb, N Scherbaum
Alcohol & Alcoholism 45 (2), 143-145, 2010
632010
AWMF-Leitlinie: Cannabis-bezogene Störungen
U Bonnet, K Harries-Hedder, FM Leweke, U Schneider, P Tossmann
Fortschritte der Neurologie· Psychiatrie 72 (06), 318-329, 2004
572004
Gabapentinoid benefit and risk stratification: mechanisms over myth
H McAnally, U Bonnet, AD Kaye
Pain and therapy 9 (2), 441-452, 2020
562020
On the addictive power of gabapentinoids: a mini-review
U Bonnet, EL Richter, K Isbruch, N Scherbaum
Psychiatria Danubina 30 (2), 142-149, 2018
522018
Vermal atrophy of alcoholics correlate with serum thiamine levels but not with dentate iron concentrations as estimated by MRI
M Maschke, J Weber, U Bonnet, A Dimitrova, J Bohrenkämper, S Sturm, ...
Journal of neurology 252, 704-711, 2005
522005
Alteration of intracellular pH and activity of CA3-pyramidal cells in guinea pig hippocampal slices by inhibition of transmembrane acid extrusion
U Bonnet, T Leniger, M Wiemann
Brain research 872 (1-2), 116-124, 2000
512000
Longitudinal patterns of benzodiazepine consumption in a German cohort of methadone maintenance treatment patients
M Specka, U Bonnet, M Heilmann, F Schifano, N Scherbaum
Human Psychopharmacology: Clinical and Experimental 26 (6), 404-411, 2011
492011
系统目前无法执行此操作,请稍后再试。
文章 1–20